Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256865 · ClinicalTrials.gov registry record · Early Phase 1
Hormonal Mechanisms of Sleep Restriction
A Early Phase 1 study, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
NCT02256865 is a Early Phase 1 study that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02256865, a Early Phase 1 study, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to study the effects of sleep restriction on the production of two hormones, cortisol and testosterone. The investigators aim to show that changing these hormones leads to insulin resistance, which is an important cause of type 2 diabetes mellitus. The investigators may also study the effect of sleep restriction on your food intake and cravings, mood, inflammation, metabolism (including bone), and other hormones. Inflammation is your body's response to stress and injury. Bone metabolism is a process of how your body regenerates (renews) new bone cells and removes old bone cells. Hormones are natural substances (materials) that are produced in the body and that influences (effects) the way the body grows or develops.
Interventions
- DRUG Hydrocortisone
- DRUG Testosterone
- DRUG Ketoconazole
- DRUG Placebo for ketoconazole
- DRUG Placebo for hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-10 |
| Est. Completion | 2023-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256865
The ClinicalTrials.gov registry entry for NCT02256865 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Hydrocortisone is the first listed.
NCT02256865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02256865 about?
NCT02256865 is a clinical study titled "Hormonal Mechanisms of Sleep Restriction". The purpose of this study is to study the effects of sleep restriction on the production of two hormones, cortisol and testosterone. The investigators aim to show that changing these hormones leads to insulin resistance, which is an important cause of type 2 diabetes mellitus. The investigators may ...
What is the current status of trial NCT02256865?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2014-10. Estimated completion is 2023-10.
What interventions are being tested in trial NCT02256865?
The interventions under investigation include: Hydrocortisone (DRUG), Testosterone (DRUG), Ketoconazole (DRUG), Placebo for ketoconazole (DRUG), Placebo for hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT02256865?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.